Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Marinus Pharmaceuticals Inc.
Sponsor

Marinus Pharmaceuticals Inc.

United States 5 Radnor Corporate Center Suite 500, 19087-4535, United States

About the sponsor

Marinus Pharmaceuticals Inc. focuses on clinical research in difficult-to-treat epilepsy conditions, with particular attention to seizure control in patients whose symptoms remain active despite standard treatment.

  • Refractory Status Epilepticus
  • Adjunctive anti-seizure therapy
  • Intravenous treatment for acute seizure management

The sponsor’s work in this area centers on therapeutic options for severe seizure emergencies and ongoing seizure burden in clinical settings requiring intensive neurological care.

About Specializations

Marinus Pharmaceuticals Inc. runs clinical trials in conditions such as Epilepsy, Status epilepticus, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Epilepsy

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ganaxolone
  • Sponsor:Marinus Pharmaceuticals Inc.

Status epilepticus

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ganaxolone
  • Sponsor:Marinus Pharmaceuticals Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.